Compound details
(2S)-1-(1H-indol-3-yl)-3-[[5-(3-methyl-2H-indazol-5-yl)-3-pyridinyl]oxy]-2-propanamine
| Compound ID | CDAMM00172 |
|---|---|
| Common name | (2S)-1-(1H-indol-3-yl)-3-[[5-(3-methyl-2H-indazol-5-yl)-3-pyridinyl]oxy]-2-propanamine | IUPAC name | 1-(1H-indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan-2-amine |
| Molecular formula | C24H23N5O |
| Retention time | 28.56 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 398.197 | Theoretical mz | 398.198 |
| Error | 0.57 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 4.6738 |
| Inchi key | YWTBGJGMTBHQTM-TWYLJJHKNA-N |
|---|---|
| Smiles | CC1=C2C=C(C=CC2=NN1)C3=CC(=CN=C3)OCC(CC4=CNC5=CC=CC=C54)N |
| Superclass | Organoheterocyclic compounds |
| Class | Indoles and derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| O15379 | HDAC3 | Histone deacetylase 3 | T05090 | SEA |
| Q15118 | PDK1 | Pyruvate dehydrogenase kinase isoform 1 | T20891 | SEA |
| Q92769 | HDAC2 | Histone deacetylase 2 | T51191 | SEA |
| P53779 | MAPK10 | c-Jun N-terminal kinase 3 | T85421 | SEA |
| P04150 | NR3C1 | Glucocorticoid receptor | T40016 | SEA |
| P49137 | MAPKAPK2 | MAP kinase-activated protein kinase 2 | T21307 | SEA |
| P08253 | MMP2 | Matrix metalloproteinase 2 | T68251 | SEA |
| P22894 | MMP8 | Matrix metalloproteinase 8 | T08856 | SEA |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SEA |
| P11309 | PIM1 | Serine/threonine-protein kinase PIM1 | T50594 | SEA |
| P53667 | LIMK1 | LIM domain kinase 1 | T70840 | SEA |
| P24941 | CDK2 | Cyclin-dependent kinase 2 | T70176 | SEA |
| P36888 | FLT3 | Tyrosine-protein kinase receptor FLT3 | T74312 | SEA |
| Q9P1W9 | PIM2 | Serine/threonine-protein kinase PIM2 | T07279 | SEA |
| Q86V86 | PIM3 | Serine/threonine-protein kinase PIM3 | T16596 | SEA |
| P35270 | SPR | Substance-P receptor | T47094 | SEA |
| P32245 | MC4R | Melanocortin receptor 4 | T72458 | SEA |
| Q92847 | GHSR | Ghrelin receptor | T59604 | SEA |
| Q01726 | MC1R | Melanocortin receptor 1 | T35842 | SEA |
| P41968 | MC3R | Melanocortin receptor 3 | T76846 | SEA |
| O75116 | ROCK2 | Rho-associated protein kinase 2 | T06093 | SEA |
| P31749 | AKT1 | Serine/threonine-protein kinase AKT | T67619 | SEA |
| P49841 | GSK3B | Glycogen synthase kinase-3 beta | T70977 | SEA |
| O96017 | CHEK2 | Serine/threonine-protein kinase Chk2 | T28713 | SEA |
| P41743 | PRKCI | Protein kinase C iota | T83174 | SEA |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SEA |
| P35916 | FLT4 | Vascular endothelial growth factor receptor 3 | T07303 | SEA |
| Q9HBH9 | MKNK2 | MAP kinase signal-integrating kinase 2 | T99160 | SEA |
| O00444 | PLK4 | Serine/threonine-protein kinase PLK4 | T71374 | SEA |
| Q9Y463 | DYRK1B | Dual specificity tyrosine-phosphorylation-regulated kinase 1B | T82720 | SEA |
| Q14289 | PTK2B | Protein tyrosine kinase 2 beta | T07087 | SEA |
| O00311 | CDC7 | CDC7/DBF4 (Cell division cycle 7-related protein kinase/Activator of S phase kinase) | T81358 | SEA |
| P42892 | ECE1 | Endothelin-converting enzyme 1 | T50970 | SEA |
| Q9NWZ3 | IRAK4 | Interleukin-1 receptor-associated kinase 4 | T55398 | SEA |
| P28482 | MAPK1 | MAP kinase ERK2 | T58970 | SEA |
| P23443 | RPS6KB1 | Ribosomal protein S6 kinase 1 | T94479 | SEA |
| Q9HAZ1 | CLK4 | Dual specificity protein kinase CLK4 | T98225 | SEA |
| P06493 | CDK1 | Cyclin-dependent kinase 1/cyclin B1 | T49898 | SEA |
| P49840 | GSK3A | Glycogen synthase kinase-3 alpha | T76910 | SEA |
| P50613 | CDK7 | Cyclin-dependent kinase 7 | T58449 | SEA |
| Q00535 | CDK5 | Cyclin-dependent kinase 5/CDK5 activator 1 | T20973 | SEA |
| P49760 | CLK2 | Dual specificity protein kinase CLK2 | T73725 | SEA |
| Q07002 | CDK18 | Serine/threonine-protein kinase PCTAIRE-3 | T27577 | SEA |
| P16591 | FER | Tyrosine-protein kinase FER | T16993 | SEA |
| P07332 | FES | Tyrosine-protein kinase FES | T29083 | SEA |
| P08922 | ROS1 | Proto-oncogene tyrosine-protein kinase ROS | T69128 | SEA |
| Q16288 | NTRK3 | NT-3 growth factor receptor | T51076 | SEA |
| P35346 | SSTR5 | Somatostatin receptor 5 | T64830 | SEA |
| P49336 | CDK8 | Cell division protein kinase 8 | T10822 | SEA |
| P30874 | SSTR2 | Somatostatin receptor 2 | T53024 | SEA |
| P31391 | SSTR4 | Somatostatin receptor 4 | T62974 | SEA |
| P30872 | SSTR1 | Somatostatin receptor 1 | T16633 | SEA |
| P32745 | SSTR3 | Somatostatin receptor 3 | T13644 | SEA |
| P32239 | CCKBR | Cholecystokinin B receptor (by homology) | T05849 | SEA |
| P31751 | AKT2 | Serine/threonine-protein kinase AKT2 | T94621 | SEA |
| Q9Y243 | AKT3 | Serine/threonine-protein kinase AKT | T71266 | SEA |
| Q13976 | PRKG1 | cGMP-dependent protein kinase 1 beta | T78543 | SEA |
| P68400 | CSNK2A1 | Casein kinase II alpha | T51565 | SEA |
| Q9UQM7 | CAMK2A | CaM kinase II alpha | T18299 | SEA |
| Q96GD4 | AURKB | Serine/threonine-protein kinase Aurora-B | T46781 | SEA |
| P14679 | TYR | Tyrosinase | T97035 | SEA |
| O15111 | CHUK | Inhibitor of NF-kappa-B kinase (IKK) | T78429 | SEA |
| O75582 | RPS6KA5 | Ribosomal protein S6 kinase alpha 5 | T50224 | SEA |
| Q13153 | PAK1 | Serine/threonine-protein kinase PAK 1 | T37961 | SEA |
| P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha 3 | T03279 | SEA |
| P19525 | EIF2AK2 | Interferon-induced, double-stranded RNA-activated protein kinase | T04831 | SEA |
| Q14680 | MELK | Maternal embryonic leucine zipper kinase | T96892 | SEA |
| O95819 | MAP4K4 | Mitogen-activated protein kinase kinase kinase kinase 4 | T71367 | SEA |
| Q9UIQ6 | LNPEP | Cystinyl aminopeptidase | T97537 | SEA |
| P15735 | PHKG2 | Phosphorylase kinase gamma subunit 2 | T69208 | SEA |
| Q9HCP0 | CSNK1G1 | Casein kinase I gamma 1 | T41702 | SEA |
| O43293 | DAPK3 | Death-associated protein kinase 3 | T81623 | SEA |
| P78368 | CSNK1G2 | Casein kinase I gamma 2 | T82773 | SEA |
| P48729 | CSNK1A1 | Casein kinase I alpha | T13075 | SEA |
| P48730 | CSNK1D | Casein kinase I delta | T87109 | SEA |
| Q13237 | PRKG2 | cGMP-dependent protein kinase 2 | T23606 | SEA |
| Q9UK32 | RPS6KA6 | Ribosomal protein S6 kinase alpha 6 | T95878 | SEA |
| P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | T63846 | SEA |
| Q2M2I8 | AAK1 | Adaptor-associated kinase | T32764 | SEA |
| Q7KZI7 | MARK2 | MAP/microtubule affinity-regulating kinase 2 | T01396 | SEA |
| Q13464 | ROCK1 | Rho-associated protein kinase 1 | T51282 | SEA |
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SEA |
| Q9BYT3 | STK33 | Serine/threonine-protein kinase 33 | T17552 | SEA |
| Q96KB5 | PBK | PDZ-binding kinase | T98642 | SEA |
| Q05513 | PRKCZ | Protein kinase C (PKC) | T59190 | SEA |
| P53778 | MAPK12 | MAP kinase p38 gamma | T79798 | SEA |
| Q14004 | CDK13 | Cyclin-dependent kinase 13 | T74839 | SEA |
| P05129 | PRKCG | Protein kinase C gamma | T47107 | SEA |
| P30530 | AXL | Tyrosine-protein kinase receptor UFO | T82383 | SEA |
| Q5VT25 | CDC42BPA | Serine or threonine-protein kinase MRCK-A | T00075 | SEA |
| O96013 | PAK4 | Serine/threonine-protein kinase PAK 4 | T98293 | SEA |
| P28336 | NMBR | Neuromedin B receptor | T68887 | SEA |
| Q16512 | PKN1 | Protein kinase N1 | T60003 | SEA |
| Q9UQM7 | CAMK2A | CaM kinase II alpha | T18299 | SEA |
| P28336 | NMBR | Neuromedin B receptor | T68887 | SEA |
| Q16513 | PKN2 | Protein kinase N2 | T94197 | SEA |
| Q9UQM7 | CAMK2A | CaM kinase II alpha | T18299 | SEA |
| Q96SB4 | SRPK1 | Serine/threonine-protein kinase SRPK1 | T94201 | SEA |
| Q9NSY1 | BMP2K | BMP-2-inducible protein kinase | T90961 | SEA |
| Q8N5S9 | CAMKK1 | CaM-kinase kinase alpha | T38134 | SEA |
| Q96RR4 | CAMKK2 | CaM-kinase kinase beta | T82262 | SEA |
| Q12851 | MAP4K2 | Mitogen-activated protein kinase kinase kinase kinase 2 | T07191 | SEA |
| P27448 | MARK3 | Serine/threonine-protein kinase c-TAK1 | T90553 | SEA |
| Q9H093 | NUAK2 | NUAK family SNF1-like kinase 2 | T55005 | SEA |
| Q9NZ08 | ERAP1 | Endoplasmic reticulum aminopeptidase 1 | T72849 | SEA |
| Q7L7X3 | TAOK1 | Serine/threonine-protein kinase TAO1 | T97016 | SEA |
| Q09013 | DMPK | Myotonin-protein kinase | T68766 | SEA |
| Q13177 | PAK2 | Serine/threonine-protein kinase PAK 2 | T07766 | SEA |
| O00418 | EEF2K | Serine/threonine-protein kinase EEF2K | T92494 | SEA |
| P35499 | SCN4A | Sodium channel protein type IV alpha subunit | T02546 | SEA |
| Q9H2X6 | HIPK2 | Homeodomain-interacting protein kinase 2 | T53952 | SEA |
| Q96PF2 | TSSK2 | Testis-specific serine/threonine-protein kinase 2 | T04413 | SEA |
| O43781 | DYRK3 | Dual-specificity tyrosine-phosphorylation regulated kinase 3 | T97149 | SEA |
| Q9H2G2 | SLK | Serine/threonine-protein kinase 2 | T57307 | SEA |
| Q9UEE5 | STK17A | Serine/threonine-protein kinase 17A | T91323 | SEA |
| O14578 | CIT | Citron Rho-interacting kinase | T91397 | SEA |
| Q06609 | RAD51 | DNA repair protein RAD51 homolog 1 | T63083 | SEA |
| Q9NR20 | DYRK4 | Dual-specificity tyrosine-phosphorylation regulated kinase 4 | T20542 | SEA |
| Q96BR1 | SGK3 | Serum-and glucocorticoid-inducible kinase SGK | T64102 | SEA |
| Q8TDC3 | BRSK1 | BR serine/threonine kinase 1 | T20053 | SEA |
| Q9Y6M4 | CSNK1G3 | Casein kinase I gamma-3 | T29728 | SEA |
| O15075 | DCLK1 | Doublecortin-like kinase 1 | T42447 | SEA |
| P78362 | SRPK2 | SRSF protein kinase 2 | T58924 | SEA |
| Q9NYE9 | HCCS4 | MLK-related kinase | T97821 | SEA |
| Q96BR1 | SGK3 | Serum-and glucocorticoid-inducible kinase SGK | T64102 | SEA |
| Q9NRM7 | LATS2 | Large tumor suppressor homolog 2 | T18390 | SEA |
| Q99755 | PIP5K1A | PtdIns(4)P-5-kinase 1 alpha | T14630 | SEA |
| Q92772 | CDKL2 | Cyclin-dependent kinase-like 2 | T44341 | SEA |
| O75385 | KIAA0722 | Serine/threonine-protein kinase ULK1 | T79307 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T05090 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | O15379 | HDAC3 |
| T05090 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O15379 | HDAC3 |
| T20891 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q15118 | PDK1 |
| T51191 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q92769 | HDAC2 |
| T51191 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q92769 | HDAC2 |
| T85421 | DI0125 | Dissociative neurological symptom disorder | [ICD-11: 6B60] | P53779 | MAPK10 |
| T40016 | DI0016 | Adaptive immunity immunodeficiency | [ICD-11: 4A01] | P04150 | NR3C1 |
| T40016 | DI0022 | Allergic/hypersensitivity disorder | [ICD-11: 4A80-4A8Z] | P04150 | NR3C1 |
| T40016 | DI0037 | Asthma | [ICD-11: CA23] | P04150 | NR3C1 |
| T40016 | DI0086 | Chronic obstructive pulmonary disease | [ICD-11: CA22] | P04150 | NR3C1 |
| T40016 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P04150 | NR3C1 |
| T40016 | DI0280 | Muscular dystrophy | [ICD-11: 8C70] | P04150 | NR3C1 |
| T40016 | DI0314 | Oesophagitis | [ICD-11: DA24] | P04150 | NR3C1 |
| T40016 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | P04150 | NR3C1 |
| T40016 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P04150 | NR3C1 |
| T40016 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P04150 | NR3C1 |
| T40016 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | P04150 | NR3C1 |
| T21307 | DI0011 | Acute laryngitis/tracheitis | [ICD-11: CA05] | P49137 | MAPKAPK2 |
| T21307 | DI0181 | Hidradenitis suppurativa | [ICD-11: ED92] | P49137 | MAPKAPK2 |
| T21307 | DI0269 | Monogenic autoinflammatory syndrome | [ICD-11: 4A60] | P49137 | MAPKAPK2 |
| T21307 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P49137 | MAPKAPK2 |
| T21307 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P49137 | MAPKAPK2 |
| T21307 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P49137 | MAPKAPK2 |
| T21307 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P49137 | MAPKAPK2 |
| T68251 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08253 | MMP2 |
| T08856 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P22894 | MMP8 |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T50594 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11309 | PIM1 |
| T50594 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11309 | PIM1 |
| T70176 | DI0060 | Brain cancer | [ICD-11: 2A00] | P24941 | CDK2 |
| T70176 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P24941 | CDK2 |
| T70176 | DI0238 | Lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | P24941 | CDK2 |
| T70176 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P24941 | CDK2 |
| T70176 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P24941 | CDK2 |
| T70176 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P24941 | CDK2 |
| T70176 | DI0406 | Thymoma | [ICD-11: 2C27] | P24941 | CDK2 |
| T74312 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P36888 | FLT3 |
| T74312 | DI0058 | Bone/articular cartilage neoplasm | [ICD-11: 2F7B] | P36888 | FLT3 |
| T74312 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | P36888 | FLT3 |
| T74312 | DI0184 | Human immunodeficiency virus disease | [ICD-11: 1C60-1C62] | P36888 | FLT3 |
| T74312 | DI0199 | Idiopathic interstitial pneumonitis | [ICD-11: CB03] | P36888 | FLT3 |
| T74312 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P36888 | FLT3 |
| T74312 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P36888 | FLT3 |
| T74312 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | P36888 | FLT3 |
| T07279 | DI0274 | Multiple myeloma | [ICD-11: 2A83] | Q9P1W9 | PIM2 |
| T07279 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9P1W9 | PIM2 |
| T47094 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P35270 | SPR |
| T47094 | DI0293 | Nausea/vomiting | [ICD-11: MD90] | P35270 | SPR |
| T72458 | DI0192 | Hypoactive sexual desire dysfunction | [ICD-11: HA00] | P32245 | MC4R |
| T72458 | DI0228 | Large intestine motility disorder | [ICD-11: DB32] | P32245 | MC4R |
| T72458 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P32245 | MC4R |
| T59604 | DI0087 | Chronic pain | [ICD-11: MG30] | Q92847 | GHSR |
| T59604 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | Q92847 | GHSR |
| T35842 | DI0192 | Hypoactive sexual desire dysfunction | [ICD-11: HA00] | Q01726 | MC1R |
| T35842 | DI0205 | Inborn porphyrin/heme metabolism error | [ICD-11: 5C58] | Q01726 | MC1R |
| T76846 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | P41968 | MC3R |
| T76846 | DI0378 | Sexual dysfunction | [ICD-11: HA00-HA01] | P41968 | MC3R |
| T76846 | DI0417 | Type 2 diabetes mellitus | [ICD-11: 5A11] | P41968 | MC3R |
| T06093 | DI0168 | Graft-versus-host disease | [ICD-11: 4B24] | O75116 | ROCK2 |
| T67619 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P31749 | AKT1 |
| T70977 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | P49841 | GSK3B |
| T28713 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O96017 | CHEK2 |
| T83174 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P41743 | PRKCI |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |
| T07303 | DI0361 | Renal cell carcinoma | [ICD-11: 2C90] | P35916 | FLT4 |
| T99160 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9HBH9 | MKNK2 |
| T99160 | DI0095 | Colorectal cancer | [ICD-11: 2B91] | Q9HBH9 | MKNK2 |
| T99160 | DI0235 | Liver cancer | [ICD-11: 2C12] | Q9HBH9 | MKNK2 |
| T99160 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9HBH9 | MKNK2 |
| T99160 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q9HBH9 | MKNK2 |
| T71374 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O00444 | PLK4 |
| T81358 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O00311 | CDC7 |
| T81358 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O00311 | CDC7 |
| T55398 | DI0039 | Atopic eczema | [ICD-11: EA80] | Q9NWZ3 | IRAK4 |
| T55398 | DI0109 | Cutaneous lupus erythematosus | [ICD-11: EB50-EB5Z] | Q9NWZ3 | IRAK4 |
| T55398 | DI0241 | Lymphoma | [ICD-11: 2A80-2A86] | Q9NWZ3 | IRAK4 |
| T55398 | DI0339 | Postoperative inflammation | [ICD-11: 1A00-CA43] | Q9NWZ3 | IRAK4 |
| T55398 | DI0351 | Psoriasis | [ICD-11: EA90] | Q9NWZ3 | IRAK4 |
| T55398 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9NWZ3 | IRAK4 |
| T58970 | DI0036 | Arteries/arterioles disorder | [ICD-11: BD52] | P28482 | MAPK1 |
| T58970 | DI0252 | Melanoma | [ICD-11: 2C30] | P28482 | MAPK1 |
| T58970 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P28482 | MAPK1 |
| T58970 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28482 | MAPK1 |
| T94479 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P23443 | RPS6KB1 |
| T94479 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P23443 | RPS6KB1 |
| T94479 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P23443 | RPS6KB1 |
| T49898 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P06493 | CDK1 |
| T49898 | DI0238 | Lung cancer | [ICD-11: 2C25] | P06493 | CDK1 |
| T49898 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P06493 | CDK1 |
| T49898 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | P06493 | CDK1 |
| T49898 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06493 | CDK1 |
| T76910 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P49840 | GSK3A |
| T58449 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P50613 | CDK7 |
| T58449 | DI0238 | Lung cancer | [ICD-11: 2C25] | P50613 | CDK7 |
| T58449 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P50613 | CDK7 |
| T58449 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P50613 | CDK7 |
| T20973 | DI0308 | Obesity | [ICD-11: 5B80-5B81] | Q00535 | CDK5 |
| T69128 | DI0238 | Lung cancer | [ICD-11: 2C25] | P08922 | ROS1 |
| T69128 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | P08922 | ROS1 |
| T51076 | DI0303 | Non-small-cell lung cancer | [ICD-11: 2C25] | Q16288 | NTRK3 |
| T51076 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q16288 | NTRK3 |
| T64830 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P35346 | SSTR5 |
| T10822 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P49336 | CDK8 |
| T10822 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | P49336 | CDK8 |
| T53024 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P30874 | SSTR2 |
| T53024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P30874 | SSTR2 |
| T53024 | DI0337 | Pituitary gland disorder | [ICD-11: 5A60-5A61] | P30874 | SSTR2 |
| T62974 | DI0087 | Chronic pain | [ICD-11: MG30] | P31391 | SSTR4 |
| T62974 | DI0179 | Hepatitis virus infection | [ICD-11: 1E50-1E51] | P31391 | SSTR4 |
| T16633 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P30872 | SSTR1 |
| T16633 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P30872 | SSTR1 |
| T13644 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | P32745 | SSTR3 |
| T05849 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P32239 | CCKBR |
| T05849 | DI0327 | Pancreatic internal secretion disorder | [ICD-11: 5A4Y] | P32239 | CCKBR |
| T71266 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q9Y243 | AKT3 |
| T51565 | DI0104 | Coronavirus infection | [ICD-11: 1D92] | P68400 | CSNK2A1 |
| T51565 | DI0235 | Liver cancer | [ICD-11: 2C12] | P68400 | CSNK2A1 |
| T51565 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P68400 | CSNK2A1 |
| T18299 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UQM7 | CAMK2A |
| T46781 | DI0009 | Acute diabete complication | [ICD-11: 5A2Y] | Q96GD4 | AURKB |
| T46781 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q96GD4 | AURKB |
| T97035 | DI0007 | Acquired hypermelanosis | [ICD-11: ED60] | P14679 | TYR |
| T97035 | DI0008 | Acquired hypomelanotic disorder | [ICD-11: ED63] | P14679 | TYR |
| T78429 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | O15111 | CHUK |
| T03279 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P51812 | RPS6KA3 |
| T96892 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | Q14680 | MELK |
| T96892 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q14680 | MELK |
| T96892 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q14680 | MELK |
| T96892 | DI0250 | Mature B-cell lymphoma | [ICD-11: 2A85] | Q14680 | MELK |
| T96892 | DI0284 | Myelodysplastic syndrome | [ICD-11: 2A37] | Q14680 | MELK |
| T96892 | DI0286 | Myeloproliferative neoplasm | [ICD-11: 2A20] | Q14680 | MELK |
| T13075 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | P48729 | CSNK1A1 |
| T13075 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P48729 | CSNK1A1 |
| T87109 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | P48730 | CSNK1D |
| T87109 | DI0326 | Pancreatic cancer | [ICD-11: 2C10] | P48730 | CSNK1D |
| T95878 | DI0249 | Mature B-cell leukaemia | [ICD-11: 2A82] | Q9UK32 | RPS6KA6 |
| T32764 | DI0163 | General pain disorder | [ICD-11: 8E43] | Q2M2I8 | AAK1 |
| T51282 | DI0166 | Glaucoma | [ICD-11: 9C61] | Q13464 | ROCK1 |
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T98642 | DI0291 | Nasopharyngeal cancer | [ICD-11: 2B6B] | Q96KB5 | PBK |
| T59190 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q05513 | PRKCZ |
| T79798 | DI0403 | Thrombocytopenia | [ICD-11: 3B64] | P53778 | MAPK12 |
| T74839 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q14004 | CDK13 |
| T47107 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P05129 | PRKCG |
| T47107 | DI0248 | Mastocytosis | [ICD-11: 2A21] | P05129 | PRKCG |
| T82383 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P30530 | AXL |
| T98293 | DI0245 | Malignant haematopoietic neoplasm | [ICD-11: 2B33] | O96013 | PAK4 |
| T98293 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | O96013 | PAK4 |
| T68887 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P28336 | NMBR |
| T68887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28336 | NMBR |
| T18299 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UQM7 | CAMK2A |
| T68887 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | P28336 | NMBR |
| T68887 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P28336 | NMBR |
| T18299 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | Q9UQM7 | CAMK2A |
| T94201 | DI0365 | Retinopathy | [ICD-11: 9B71] | Q96SB4 | SRPK1 |
| T07191 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q12851 | MAP4K2 |
| T90553 | DI0334 | Peritoneal cancer | [ICD-11: 2C51] | P27448 | MARK3 |
| T90553 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P27448 | MARK3 |
| T68766 | DI0288 | Myotonic disorder | [ICD-11: 8C71] | Q09013 | DMPK |
| T92494 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | O00418 | EEF2K |
| T02546 | DI0281 | Musculoskeletal disorder | [ICD-11: FA00-FC0Z] | P35499 | SCN4A |
| T63083 | DI0048 | B-cell lymphoma | [ICD-11: 2A86] | Q06609 | RAD51 |
| T63083 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q06609 | RAD51 |